AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

ALCIDION GROUP LTD

0.084

+0.0011.20%

Volume:1.46M

Turnover:125.80K

Market Cap:112.81M

PE:-22.66

High:0.089

Open:0.085

Low:0.084

Close:0.083

Loading ...

Overview Company News Filings

Alcidion Group Reports Positive Operating Cashflow in Fiscal Q3, Shares Jump 11%

MT Newswires Live

Alcidion Group Ltd - FY25 Ebitda Expected to Exceed a$3.0M and to Deliver a Positive Full Year Cashflow Result

THOMSON REUTERS

Alcidion Group Ltd - Q3 New Tcv Sales of a$48.8M With a$11.5M Expected to Be Recognised in FY25

THOMSON REUTERS

Investing in Alcidion Group (ASX:ALC) a year ago would have delivered you a 65% gain

Simply Wall St.

When Will Alcidion Group Limited (ASX:ALC) Become Profitable?

Simply Wall St.

Alcon Buys Majority Stake in Aurion Biotech

MT Newswires Live

Alcon Gets CE Mark for Clareon Vivity Intraocular Lens

MT Newswires Live

Alcon to Acquire Lensar for $430 Million

MT Newswires Live

Alcidion Bull Sees Chance of a Full-Year Profit -- Market Talk

Is It Too Late To Consider Buying Alcidion Group Limited (ASX:ALC)?

Simply Wall St.

This Insider Has Just Sold Shares In Alcidion Group

Simply Wall St.

Alcidion Group CEO Sells Shares

MT Newswires Live

Alcon Stock Gets Relative Strength Rating Lift

BRIEF-Alcidion Group Announces Share Sale By Managing Director & CEO

Alcidion Group Ltd - Kate Quirke Sold 5.0 Mln Shares, via an Pre-Market Block Trade

THOMSON REUTERS

Alcidion Group Ltd - Share Sale by Managing Director & CEO

THOMSON REUTERS

Alcidion Group Ltd (ASX:ALC) H1 2025 Earnings Call Highlights: Record Sales and Strategic ...

BRIEF-Alcidion Group Says Confident Of Positive EBITDA And Cashflow Result For FY25

Up 94% in a year, why is this ASX healthcare stock rocketing again today?

Alcidion Group H1 Net Income AUD 890 Thousand

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ALC.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ALC.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALC.AU\",,,,,undefined,":{"symbol":"ALC.AU","market":"AU","secType":"STK","nameCN":"ALCIDION GROUP LTD","latestPrice":0.084,"timestamp":1745475120000,"preClose":0.083,"halted":0,"volume":1458843,"delay":0,"nameEN":"ALCIDION GROUP LTD","floatShares":1003132617,"shares":1342952696,"eps":-0.003707,"marketStatus":"Not Yet Opened","change":0.001,"latestTime":"04-24 16:12:00 AEST","open":0.085,"high":0.089,"low":0.084,"amount":125797,"amplitude":0.060241,"askPrice":0.088,"askSize":50000,"bidPrice":0.084,"bidSize":39999,"shortable":3,"etf":0,"ttmEps":-0.003707,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1745798400000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.083,"openAndCloseTimeList":[[1745452800000,1745474400000]],"volumeRatio":0.9164528464901819,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALC.AU\",,,,,undefined,":{"symbol":"ALC.AU","floatShares":1003132617,"roa":"-2.85%","roe":"-5.63%","lyrEps":-0.006394,"volumeRatio":0.9164528464901819,"shares":1342952696,"dividePrice":0,"high":0.089,"amplitude":0.060241,"preClose":0.083,"low":0.084,"week52Low":0.045,"pbRate":"1.32","psRate":"3.17","week52High":0.115,"institutionHeld":0,"latestPrice":0.084,"committee":-0.111123,"eps":-0.003707,"divideRate":0,"volume":1458843,"delay":0,"ttmEps":-0.003707,"open":0.085,"prevYearClose":0.06,"prevWeekClose":0.084,"prevMonthClose":0.082,"prevQuarterClose":0.082,"fiveDayClose":0.074,"twentyDayClose":0.084,"sixtyDayClose":0.063},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ALC.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2529367872","title":"Alcidion Group Reports Positive Operating Cashflow in Fiscal Q3, Shares Jump 11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529367872","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529367872?lang=en_us&edition=fundamental","pubTime":"2025-04-22 09:51","pubTimestamp":1745286706,"startTime":"0","endTime":"0","summary":"Alcidion Group  reported cash receipts of AU$13.1 million with a positive operating cashflow of $AU2.5 million in the fiscal third quarter ended March, compared with a cash outflow of AU$1.4 million in the same period in the previous year, according to a Tuesday Australian bourse filing.Its fiscal year contracted revenue, including sold and renewal, stands at AU$40.2 million at the end of fiscal Q3.Alcidion generated fiscal Q3 new sales of AU$48.8 million, with around AU$11.5 million expected to be recognized as revenue in the fiscal year ending June.It also updated its guidance for the fiscal year with revenue expected to be at least AU$40.2 million and earnings before interest, taxes, depreciation, and amortization expected to exceed AU$3 million.Its shares jumped 11% in recent trading on Tuesday.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ALC.AU"],"gpt_icon":0},{"id":"2529735111","title":"Alcidion Group Ltd - FY25 Ebitda Expected to Exceed a$3.0M and to Deliver a Positive Full Year Cashflow Result","url":"https://stock-news.laohu8.com/highlight/detail?id=2529735111","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529735111?lang=en_us&edition=fundamental","pubTime":"2025-04-22 06:24","pubTimestamp":1745274244,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250421:nFWN3QX05J:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ALC.AU","BK7094"],"gpt_icon":0},{"id":"2529112351","title":"Alcidion Group Ltd - Q3 New Tcv Sales of a$48.8M With a$11.5M Expected to Be Recognised in FY25","url":"https://stock-news.laohu8.com/highlight/detail?id=2529112351","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529112351?lang=en_us&edition=fundamental","pubTime":"2025-04-22 06:24","pubTimestamp":1745274244,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250421:nFWN3QX05J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ALC.AU","BK7094"],"gpt_icon":0},{"id":"2529587133","title":"Investing in Alcidion Group (ASX:ALC) a year ago would have delivered you a 65% gain","url":"https://stock-news.laohu8.com/highlight/detail?id=2529587133","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529587133?lang=en_us&edition=fundamental","pubTime":"2025-04-22 04:17","pubTimestamp":1745266656,"startTime":"0","endTime":"0","summary":"If you want to compound wealth in the stock market, you can do so by buying an index fund. But you can significantly boost your returns by picking above-average stocks. To wit, the Alcidion Group Limited  share price is 65% higher than it was a year ago, much better than the market return of around 0.2%  in the same period. If it can keep that out-performance up over the long term, investors will do very well!Unfortunately the longer term returns are not so good, with the stock falling 62% in the last three years.So let's assess the underlying fundamentals over the last 1 year and see if they've moved in lock-step with shareholder returns.We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free.In the last year Alcidion Group saw its revenue shrink by 12%. Despite the lack of revenue growth, the stock has returned a solid 65% the last twelve months. We can correlate the share price rise with revenue or profit growth, but it see","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/investing-alcidion-group-asx-alc-201736570.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["LU2265009873.SGD","BK4198","ALC","BK7094","LU1804176565.USD","ALC.AU","BK4534"],"gpt_icon":0},{"id":"2525095555","title":"When Will Alcidion Group Limited (ASX:ALC) Become Profitable?","url":"https://stock-news.laohu8.com/highlight/detail?id=2525095555","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525095555?lang=en_us&edition=fundamental","pubTime":"2025-04-07 07:48","pubTimestamp":1743983306,"startTime":"0","endTime":"0","summary":"We feel now is a pretty good time to analyse Alcidion Group Limited's ( ASX:ALC ) business as it appears the company...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-alc/alcidion-group-shares/news/when-will-alcidion-group-limited-asxalc-become-profitable","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7094","LU2265009873.SGD","ALC","BK4198","LU1804176565.USD","BK4534","ALC.AU"],"gpt_icon":0},{"id":"2522355259","title":"Alcon Buys Majority Stake in Aurion Biotech","url":"https://stock-news.laohu8.com/highlight/detail?id=2522355259","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522355259?lang=en_us&edition=fundamental","pubTime":"2025-03-27 05:00","pubTimestamp":1743022811,"startTime":"0","endTime":"0","summary":"Alcon  said late Wednesday it has acquired a majority stake in Aurion Biotech, a company developing cell therapies to treat eye diseases.Financial details weren't provided.Aurion will operate as a separate company to advance its cell therapy asset AURN001 into phase 3 to treat corneal edema secondary to corneal endothelial disease during H2, Alcon said.Aurion has received breakthrough therapy designation from the US Food and Drug Administration for AURN001, Alcon said.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ALC.AU","BK7094","LU2265009873.SGD","BK4198","LU1804176565.USD","BK4534","ALC"],"gpt_icon":0},{"id":"2522335097","title":"Alcon Gets CE Mark for Clareon Vivity Intraocular Lens","url":"https://stock-news.laohu8.com/highlight/detail?id=2522335097","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522335097?lang=en_us&edition=fundamental","pubTime":"2025-03-25 16:24","pubTimestamp":1742891070,"startTime":"0","endTime":"0","summary":"Alcon (ALC) said Tuesday it has received a CE Mark for its Clareon Vivity intraocular lens.Commercial rollout for the product is expected in Europe in early Q2, the company said.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ALC","BK4585","LU1804176565.USD","LU2265009873.SGD","BK7094","BK4588","BK4198","BK4534","BK4109","CE","ALC.AU"],"gpt_icon":0},{"id":"2521728511","title":"Alcon to Acquire Lensar for $430 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2521728511","media":"MT Newswires Live","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521728511?lang=en_us&edition=fundamental","pubTime":"2025-03-24 20:24","pubTimestamp":1742819073,"startTime":"0","endTime":"0","summary":"Alcon  said Monday it is planning to acquire Lensar  for a total consideration of about $430 million.Under the terms of the deal, Alcon will purchase all outstanding shares of Lensar for $14 per share in cash, with an additional non-tradeable contingent value right offering up to $2.75 per share in cash, conditioned on the achievement of 614,000 cumulative procedures with Lensar's products between Jan. 1, 2026, and Dec. 31, 2027.The acquisition includes the Ally Robotic Cataract Laser Treatment System, Streamline software technology, and Lensar's legacy laser system.The transaction is expected to close in mid-to-late 2025.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ALC","BK4082","BK4534","BK4198","ALC.AU","LU1804176565.USD","BK7094","LNSR","LU2265009873.SGD"],"gpt_icon":0},{"id":"2520996123","title":"Alcidion Bull Sees Chance of a Full-Year Profit -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2520996123","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520996123?lang=en_us&edition=fundamental","pubTime":"2025-03-19 10:51","pubTimestamp":1742352660,"startTime":"0","endTime":"0","summary":"0251 GMT - Alcidion's new bull reckons that the healthcare software provider is well placed to deliver positive annual earnings, and maybe even a net profit. Bell Potter analyst Thomas Wakim raises his recommendation on the stock to buy from hold, telling clients in a note that a combination of a cost-cutting restructure with the signing of a large-scale patient-record contract has already delivered modestly positive 1H Ebitda. With A$8 million in licensing revenue scheduled to be recognized in 2H, Wakim anticipates a welcome shift in profitability across Alcidion's full-year result. Bell Potter keeps a A$0.11 target price on the stock, which is down 1.25% at A$0.079. ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALC.AU","BK7094"],"gpt_icon":0},{"id":"2518870992","title":"Is It Too Late To Consider Buying Alcidion Group Limited (ASX:ALC)?","url":"https://stock-news.laohu8.com/highlight/detail?id=2518870992","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518870992?lang=en_us&edition=fundamental","pubTime":"2025-03-12 05:43","pubTimestamp":1741729425,"startTime":"0","endTime":"0","summary":"While Alcidion Group Limited  might not have the largest market cap around , it received a lot of attention from a substantial price increase on the ASX over the last few months. The recent rally in share prices has nudged the company in the right direction, though it still falls short of its yearly peak. As a small cap stock, which tends to lack high analyst coverage, there is generally more of an opportunity for mispricing as there is less activity to push the stock closer to fair value. Is there still an opportunity here to buy?Let’s take a look at Alcidion Group’s outlook and value based on the most recent financial data to see if the opportunity still exists.With this in mind, we wouldn't consider investing in a stock unless we had a thorough understanding of the risks.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/too-consider-buying-alcidion-group-214345136.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["ALC.AU","BK7094","BK4198","ALC","LU1804176565.USD","LU2265009873.SGD","BK4534"],"gpt_icon":0},{"id":"2517020931","title":"This Insider Has Just Sold Shares In Alcidion Group","url":"https://stock-news.laohu8.com/highlight/detail?id=2517020931","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517020931?lang=en_us&edition=fundamental","pubTime":"2025-03-07 04:55","pubTimestamp":1741294542,"startTime":"0","endTime":"0","summary":"Anyone interested in Alcidion Group Limited ( ASX:ALC ) should probably be aware that the Group MD, Kate Quirke...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-alc/alcidion-group-shares/news/this-insider-has-just-sold-shares-in-alcidion-group","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7094","ALC.AU"],"gpt_icon":0},{"id":"2517989424","title":"Alcidion Group CEO Sells Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2517989424","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517989424?lang=en_us&edition=fundamental","pubTime":"2025-03-05 05:20","pubTimestamp":1741123242,"startTime":"0","endTime":"0","summary":"Alcidon Group (ASX:ALC) Chief Executive Kate Quirke sold 5 million fully paid ordinary shares in the company via a premarket block trade, according to a Tuesday filing with the Australian bourse.Quirke now holds about 43.6 million shares representing 3.2% of the total issued shares, per the filing.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7094","XJO.AU","XAO.AU","ALC.AU","XKO.AU"],"gpt_icon":0},{"id":"2517985921","title":"Alcon Stock Gets Relative Strength Rating Lift","url":"https://stock-news.laohu8.com/highlight/detail?id=2517985921","media":"Blockhead","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517985921?lang=en_us&edition=fundamental","pubTime":"2025-03-05 04:04","pubTimestamp":1741118640,"startTime":"0","endTime":"0","summary":"A Relative Strength Rating upgrade for Alcon shows improving technical performance. Will it continue?","market":"nz","thumbnail":"https://www.investors.com/wp-content/uploads/2017/05/IRU4-150x150.jpg","type":0,"news_type":0,"thumbnails":["https://www.investors.com/wp-content/uploads/2017/05/IRU4-150x150.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.investors.com/news/alcon-stock-gets-relative-strength-lift/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"investor_business_daily_highlight","symbols":["RS","ALC","BK4534","LU2265009873.SGD","BK4006","ALC.AU","BK7094","LU1804176565.USD","BK4198"],"gpt_icon":0},{"id":"2516648783","title":"BRIEF-Alcidion Group Announces Share Sale By Managing Director & CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2516648783","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516648783?lang=en_us&edition=fundamental","pubTime":"2025-03-04 15:03","pubTimestamp":1741071809,"startTime":"0","endTime":"0","summary":"BRIEF-Alcidion Group Announces Share Sale By Managing Director & CEOMarch 4 (Reuters) - Alcidion Group Ltd ALC.AX:SHARE SALE BY MANAGING DIRECTOR & CEOKATE QUIRKE SOLD 5.0 MILLION SHARES, VIA AN PRE-MARKET BLOCK TRADEFurther company coverage: ALC.AX ((Reuters.Briefs@thomsonreuters.com;;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250304:nFWN3PM12G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALC.AU","BK7094"],"gpt_icon":0},{"id":"2516161110","title":"Alcidion Group Ltd - Kate Quirke Sold 5.0 Mln Shares, via an Pre-Market Block Trade","url":"https://stock-news.laohu8.com/highlight/detail?id=2516161110","media":"THOMSON REUTERS","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516161110?lang=en_us&edition=fundamental","pubTime":"2025-03-04 13:15","pubTimestamp":1741065354,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250304:nFWN3PM12G:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Alcidion Group Ltd - Kate Quirke Sold 5.0 Mln Shares, via an Pre-Market Block Trade","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7094","ALC.AU"],"gpt_icon":0},{"id":"2516111706","title":"Alcidion Group Ltd - Share Sale by Managing Director & CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2516111706","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516111706?lang=en_us&edition=fundamental","pubTime":"2025-03-04 13:15","pubTimestamp":1741065354,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250304:nFWN3PM12G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7094","ALC.AU"],"gpt_icon":0},{"id":"2514873123","title":"Alcidion Group Ltd (ASX:ALC) H1 2025 Earnings Call Highlights: Record Sales and Strategic ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2514873123","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514873123?lang=en_us&edition=fundamental","pubTime":"2025-02-27 17:00","pubTimestamp":1740646830,"startTime":"0","endTime":"0","summary":"For the complete transcript of the earnings call, please refer to the full earnings call transcript.Alcidion Group Ltd  reported a record year-to-date new sales revenue of $61.3 million, indicating strong sales momentum.The company signed five new material contracts in the first eight months of the financial year, showcasing successful market penetration.Alcidion Group Ltd  achieved a positive underlying EBITDA of $500,000, reflecting a significant improvement of $3.3 million from the previous year.The company has a strong recurring revenue stream, with 78% of its revenue being recurring annually.Alcidion Group Ltd  is expanding its presence in key markets, including Australia, New Zealand, and the UK, with notable contract wins and renewals.There was a $1.2 million decrease in implementation revenue due to the nearing completion of the ADF contract.The company faces challenges in expanding beyond its current markets, with no immediate plans for aggressive geographical expansion.A: Uni","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/alcidion-group-ltd-asx-alc-090030553.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["ALC","ALC.AU"],"gpt_icon":0},{"id":"2514132578","title":"BRIEF-Alcidion Group Says Confident Of Positive EBITDA And Cashflow Result For FY25","url":"https://stock-news.laohu8.com/highlight/detail?id=2514132578","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514132578?lang=en_us&edition=fundamental","pubTime":"2025-02-27 09:11","pubTimestamp":1740618717,"startTime":"0","endTime":"0","summary":"BRIEF-Alcidion Group Says Confident Of Positive EBITDA And Cashflow Result For FY25Feb 27  - Alcidion Group Ltd ALC.AX:H1 ADJUSTED EBITDA AUD 500 THOUSANDCONFIDENT OF POSITIVE EBITDA AND CASHFLOW RESULT FOR FY25H1 NET INCOME AUD 890 THOUSANDH1 REVENUE AUD 17.6 MILLIONFurther company coverage: ALC.AX ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250227:nPLX8D11A9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7094","ALC.AU"],"gpt_icon":0},{"id":"2514981197","title":"Up 94% in a year, why is this ASX healthcare stock rocketing again today?","url":"https://stock-news.laohu8.com/highlight/detail?id=2514981197","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514981197?lang=en_us&edition=fundamental","pubTime":"2025-02-27 08:12","pubTimestamp":1740615153,"startTime":"0","endTime":"0","summary":"Alcidion noted that the 7% decline in revenue was expected. The company said this was driven by the known reduction in non-recurring product implementation due to the near-term completion of its project implementation work for the Leidos Australia contract. Over the half, the ASX healthcare stock signed new material contracts for its Miya Precision platform with Hume Rural Health Alliance, North Adelaide Local Health Network, and Peninsula Health. What did management say?Looking at what could impact the ASX healthcare stock in the months ahead, Alcidion pointed to \"strong momentum\" in the second half of FY 2025, with two new sizeable contracts announced since 31 December. \"Importantly, these contracts continue to build our annual recurring revenue, which is increasingly valuable given the critical nature of our technology offering and long-standing nature of our customer relationships,\" Quirke said. Alcidion said its contracted and renewal revenue currently stands at $39.5 million. Man","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/02/27/up-94-in-a-year-why-is-this-asx-healthcare-stock-rocketing-again-today/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["XJO.AU","XAO.AU","XKO.AU","BK7094","ALC.AU"],"gpt_icon":0},{"id":"2514985818","title":"Alcidion Group H1 Net Income AUD 890 Thousand","url":"https://stock-news.laohu8.com/highlight/detail?id=2514985818","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514985818?lang=en_us&edition=fundamental","pubTime":"2025-02-27 05:23","pubTimestamp":1740605027,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250226:nPLX8D11A9:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ALC.AU","BK7094"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":44,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ALC.AU\",params:#limit:5,,,undefined,":[{"date":"2025-04-22","symbol":"ALC.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1745280000000,"name":null,"time":"","dateTimestamp":1745244000000,"actualEps":null},{"date":"2025-02-26","symbol":"ALC.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1740524400000,"name":null,"time":"","dateTimestamp":1740488400000,"actualEps":null},{"date":"2025-01-30","symbol":"ALC.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1738191600000,"name":null,"time":"","dateTimestamp":1738155600000,"actualEps":null},{"date":"2024-08-29","symbol":"ALC.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724889600000,"name":null,"time":"","dateTimestamp":1724853600000,"actualEps":null},{"date":"2024-07-30","symbol":"ALC.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1722297600000,"name":null,"time":"","dateTimestamp":1722261600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ALC.AU\",market:\"AU\",,,undefined,":[]}}